DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 07 05 2018
revised: 12 09 2018
accepted: 28 09 2018
pubmed: 14 10 2018
medline: 6 8 2019
entrez: 14 10 2018
Statut: ppublish

Résumé

Inverse planning is an integral part of modern low-dose-rate brachytherapy. Current clinical planning systems do not exploit the total dose information and largely use the American Association of Physicists in Medicine TG-43 dosimetry formalism to ensure clinically acceptable planning times. Thus, suboptimal plans may be derived as a result of TG-43-related dose overestimation and nonconformity with dose distribution requirements. The purpose of this study was to propose an inverse planning approach that can improve planning quality by combining dose-volume information and precision without compromising the overall execution times. The dose map was generated by accumulating precomputed Monte Carlo (MC) dose kernels for each candidate source implantation site. The MC computational burden was reduced by using graphics processing unit acceleration, allowing accurate dosimetry calculations to be performed in the intraoperative environment. The proposed dose-volume histogram (DVH) fast simulated annealing optimization algorithm was evaluated using clinical plans that were delivered to 18 patients who underwent low-dose-rate prostate brachytherapy. Our method generated plans in 37.5 ± 3.2 seconds with similar prostate dose coverage, improved prostate dose homogeneity of up to 6.1%, and lower dose to the urethra of up to 4.0%. A DVH-based optimization algorithm using MC dosimetry was developed. The inclusion of the DVH requirements allowed for increased control over the optimization outcome. The optimal plan's quality was further improved by considering tissue heterogeneity.

Identifiants

pubmed: 30315873
pii: S0360-3016(18)33832-X
doi: 10.1016/j.ijrobp.2018.09.041
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

503-510

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Konstantinos A Mountris (KA)

LaTIM, INSERM, UMR 1101, Brest, France. Electronic address: konstantinos.mountris@gmail.com.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, Brest, France.

Julien Bert (J)

LaTIM, INSERM, UMR 1101, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH